Gulasal Kuryozova

6 та иш

Bukhara Medical Institute named after Abu Ali Ibn Sina

1. IMMUNOHISTOCHEMICAL CHARACTERISTICS OF ENDOMETRIAL TUMORS

   Gulasal Kuryozova

   МақолаEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.007426

2. IMMUNOHISTOCHEMICAL CHARACTERISTICS OF ENDOMETRIAL TUMORS

   Gulasal Kuryozova

   МақолаEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.007447

3. ANALYSIS OF ADVERSE PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER

   Gulasal Kuryozova

   МақолаEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.007615

4. ANALYSIS OF ADVERSE PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER

   Gulasal Kuryozova

   МақолаEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.007676

5. ANALYSIS OF ADVERSE PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER

   Gulasal Kuryozova

   МақолаEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.007726

6. ANALYSIS OF ADVERSE PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER

   Gulasal Kuryozova

   МақолаEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.007778